Bisphosphonates in hormone-refractory prostate cancer: do we have a toxicity problem?
Clarke
Noel W
NW
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010020:Osteonecrosis / Q000209:etiology / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D006728:Hormones